Glenmark Pharmaceuticals
GLENMARK.NS
#2764
Rank
โ‚ฌ4.67 B
Marketcap
16,56ย โ‚ฌ
Share price
-1.76%
Change (1 day)
94.34%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Cash on Hand

Cash on Hand as of March 2024 : โ‚ฌ0.20 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company has โ‚ฌ0.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Glenmark Pharmaceuticals - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-03-31โ‚ฌ0.16 B-4.15%
2022-03-31โ‚ฌ0.17 B20.91%
2021-03-31โ‚ฌ0.14 B-0.58%
2020-03-31โ‚ฌ0.14 B-2.35%
2019-03-31โ‚ฌ0.14 B-17.42%
2018-03-31โ‚ฌ0.17 B0.32%
2017-03-31โ‚ฌ0.17 B53.93%
2016-03-31โ‚ฌ0.11 B-0.41%
2015-03-31โ‚ฌ0.11 B16.29%
2014-03-31โ‚ฌ98.38 M11.42%
2013-03-31โ‚ฌ88.29 M80.94%
2012-03-31โ‚ฌ48.79 M57.74%
2011-03-31โ‚ฌ30.93 M74.92%
2010-03-31โ‚ฌ17.68 M66.43%
2009-03-31โ‚ฌ10.62 M-57.32%
2008-03-31โ‚ฌ24.89 M35.59%
2007-03-31โ‚ฌ18.36 M-6.19%
2006-03-31โ‚ฌ19.57 M-13.03%
2005-03-31โ‚ฌ22.5 M1377.96%
2004-03-31โ‚ฌ1.52 M